SABA Reliever Over-Reliance
Many people with asthma tend to over-rely on their short-acting β2-agonist (SABA) inhaler . Although they provide quick relief of symptoms, using SABA inhalers three or more times per week is associated with poor asthma control and can increase the risk of exacerbations and mortality [2,3].
The Blue Reliever Reliance Test – featuring a simple, five-item, evidence-based questionnaire – can support you to assess SABA over-reliance with your patients and explore their asthma management needs.
Are your asthma patients over-reliant on their SABA inhalers?